A detailed history of Virtu Financial LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 14,158 shares of LUCD stock, worth $11,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,158
Previous 34,671 59.16%
Holding current value
$11,043
Previous $28,000 57.14%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$0.67 - $1.04 $13,743 - $21,333
-20,513 Reduced 59.16%
14,158 $12,000
Q1 2024

May 20, 2024

BUY
$0.81 - $1.52 $11,206 - $21,029
13,835 Added 66.4%
34,671 $28,000
Q4 2023

Feb 26, 2024

BUY
$1.16 - $1.54 $24,169 - $32,087
20,836 New
20,836 $29,000
Q1 2023

May 01, 2023

BUY
$1.17 - $1.77 $18,187 - $27,514
15,545 New
15,545 $22,000
Q1 2022

May 17, 2022

SELL
$2.85 - $5.24 $32,373 - $59,521
-11,359 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$4.87 - $11.76 $55,318 - $133,581
11,359 New
11,359 $61,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $30.1M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.